BRCA2 and breast cancer: Indeed, Husky et al. revealed that germline mutations in BRCA2 and STK11 were associated with the risk of MGTs not only in humans but also within specific canine breeds through a WGS on 14 purebred dogs with mammary tumors from four breed-specific pedigrees [27].